gestational diabetes

Quetiapine Use During Pregnancy: What Do We Know About Reproductive Safety?

For women who require treatment with quetiapine during pregnancy, the available reproductive safety data are generally reassuring. The largest body of evidence does not suggest a meaningful increase in major congenital malformations, while metabolic effects, particularly gestational diabetes, remain an important consideration.

By |2026-09-14T16:12:12-04:00September 10th, 2026|Antipsychotic Medications, Medications and Pregnancy, Postpartum Psychiatric Disorders, Pregnancy Outcomes, PregnancyMedication, Psychiatric Disorders During Pregnancy|Comments Off on Quetiapine Use During Pregnancy: What Do We Know About Reproductive Safety?

Antipsychotic Medication Use in Pregnancy and Risk of Maternal and Neonatal Metabolic Complications

In this retrospective study of Taiwanese women using antipsychotic medications there was no observed increase in risk of metabolic complications.

By |2023-02-06T10:08:37-04:00January 25th, 2023|Antipsychotic Medications, Pregnancy & Medications|Comments Off on Antipsychotic Medication Use in Pregnancy and Risk of Maternal and Neonatal Metabolic Complications

More Data on Second Generation Antipsychotic Medications and Gestational Diabetes

Second-generation antipsychotic medications associated with high metabolic risk (quetiapine, olanzapine, and clozapine) were associated with increased risk of gestational diabetes; other antipsychotics were not.

By |2022-05-26T07:32:11-04:00May 25th, 2022|Psychiatric Disorders During Pregnancy|Comments Off on More Data on Second Generation Antipsychotic Medications and Gestational Diabetes

Clinical Update 2020: Antipsychotic Medications and Risk of Gestational Diabetes

Given the number of younger women using atypical antipsychotic medications, there is an urgent need for more accurate data regarding the reproductive safety of these medications. One important question is whether these newer antipsychotic [...]

By |2020-07-07T12:38:59-04:00July 8th, 2020|Antipsychotic Medications, Pregnancy & Medications|Comments Off on Clinical Update 2020: Antipsychotic Medications and Risk of Gestational Diabetes

New Research from the CWMH: Impact of Obesity on Pregnancy Outcomes in Women with Psychiatric Illness

Individuals with psychiatric disorders are at higher risk for obesity than the general population, as well as for medical comorbidity, such as diabetes, hypertension, hyperlipidemia, and cardiovascular disease.  Because obesity is associated with an [...]

By |2020-06-17T17:15:17-04:00June 23rd, 2020|Psychiatric Disorders During Pregnancy, Research at CWMH|Comments Off on New Research from the CWMH: Impact of Obesity on Pregnancy Outcomes in Women with Psychiatric Illness

A Meta-Analysis of Gestational Diabetes and Risk for Perinatal Depression

According to recent findings published in Diabetic Medicine, women who develop gestational diabetes may be more likely to experience depression during pregnancy and after delivery, compared to women without gestational diabetes. Over the years, we [...]

By |2019-12-23T23:40:12-04:00December 27th, 2019|Depressive Disorders, Psychiatric Disorders During Pregnancy|Comments Off on A Meta-Analysis of Gestational Diabetes and Risk for Perinatal Depression

Antidepressants and Gestational Diabetes: Maybe, but Not for Commonly Used SSRIs

A recent study looks at the risk for gestational diabetes in women taking antidepressants during pregnancy.  In this study from Quebec, women with gestational diabetes mellitus (GDM) diagnosed after the 20th week of pregnancy [...]

By |2020-08-13T16:06:30-04:00October 9th, 2019|Pregnancy & Medications|Comments Off on Antidepressants and Gestational Diabetes: Maybe, but Not for Commonly Used SSRIs
Go to Top